Abstract
The aquation and subsequent reactions of the dinuclear Pt antitumor complexes [{trans-PtCl(NH3)2}2(μ-NH2(CH2)6NH2)]2+ (1,1/t,t) and [{cis-PtCl(NH3)2}2(μ-NH2(CH2)6NH2)]2+ (1,1/c,c) in 15 mM perchlorate, acetate or phosphate solutions were followed at 298 K by [1H,15N] HSQC 2D NMR spectroscopy. Rate and equilibrium constants for the initial reversible aquation and the subsequent reversible reaction with phosphate or acetate are reported. The rate constant for the first aquation step is two-fold lower for 1,1/c,c than 1,1/t,t but the anation rate constants are similar so that the equilibrium lies further towards the chloro form for the 1,1/c,c compound. A pK a value of 6.01±0.03 was determined for the diaquated species [{cis-Pt(NH3)2(H2O)}2(μ-NH2(CH2)6NH2)]4+ (1,1/c,c-3) which is 0.4 units higher than that of the 1,1/t,t compound. The rate constants for the binding of acetate and phosphate to 1,1/t,t are similar, but the rate constant for the reverse reaction is close to ten-fold higher in the case of phosphate so that equilibrium conditions are attained more rapidly (12 h compared with 64 h). On the other hand, for 1,1/c,c the rate constants for the forward and reverse reactions with acetate and phosphate are quite similar so that equilibrium conditions are reached very slowly (80–100 h) and a greater proportion of phosphate-bound species are present. The reduced lability of the bound phosphate for 1,1/c,c is attributed to the formation of a macrochelate phosphate-bridged species which was characterized by 31P NMR and ESI-MS. The speciation profiles of 1,1/t,t and 1,1/c,c under physiological conditions are explored.
Similar content being viewed by others
Notes
The equilibrium constants pK n are not true equilibrium constants because no account has been made of the relative contributions of aqua and hydroxo ligation to the total at the given pH. This is also true for the rate constants. However, in all cases the solution pH is lower by 0.1 to 0.6 pH units than the pK a of the coordinated aqua ligand, and so the major form will be the aqua species
Abbreviations
- HSQC :
-
Heteronuclear single-quantum coherence
- ESI-MS :
-
Electrospray ionization mass spectrometry
References
Farrell N (2004) Metals Biol Syst 41:252–296
Farrell N (1995) Comments Inorg Chem 16:373–389
Farrell N, Qu Y, Hacker MP (1990) J Med Chem 33:2179–2184
Kraker AJ, Hoeschele JD, Elliott WL, Showalter HDH, Sercel AD, Farrell NP (1992) J Med Chem 35:4526–4532
Farrell N, Appleton TG, Qu Y, Roberts JD, Fontes APS, Skov KA, Wu P, Zou Y (1995) Biochemistry 34:15480–15486
Farrell N, Qu Y, Bierbach U, Valsecchi M, Menta E (1999) In: Lippert B (ed) Cisplatin: chemistry and biochemistry of a leading anticancer drug. VCHA, Wiley-VCH, Zurich, pp 479–496
Pratesi G, Perego P, Polizzi D, Righetti SC, Supino R, Caserini C, Manzotti C, Giuliani FC, Pezzoni G, Tognella S, Spinelli S, Farrell N, Zunino F (1999) Brit J Cancer 80: 1912–1919
Perego P, Caserini C, Gatti L, Carenini N, Romanelli S, Supino R, Colangelo D, Viano I, Leone R, Spinelli S, Pezzoni G, Manzotti C, Farrell N, Zunino F (1999) Mol Pharmacol 55: 528–534
Calvert AH, Thomas H, Colombo N, Gore M, Earl H, Sena L, Camboni G, Liati P, Sessa C (2001) Eur J Cancer 37(Suppl6):Poster Discussion 965
Zehnulova J, Kasparková J, Farrell N, Brabec V (2001) J Biol Chem 276: 22191–22199
Brabec V, Kasparková J, Vrána O, Nováková O, Cox JW, Qu Y, Farrell N (1999) Biochemistry 38: 6781–6790
Kloster MBG, Hannis JC, Muddiman DC, Farrell N (1999) Biochemistry 38: 14731–14737
Kasparková J, Nováková O, Vrána O, Farrell N, Brabec V (1999) Biochemistry 38: 10997–11005
Kasparková J, Zehnulova J, Farrell N, Brabec V (2002) J Biol Chem 277: 48076–48086
Berners-Price SJ, Barnham KJ, Frey U, Sadler PJ (1996) Chem Eur J 2: 1283–1291
Davies MS, Berners-Price SJ, Hambley TW (1998) J Am Chem Soc 120: 11380–11390
Davies MS, Berners-Price SJ, Hambley TW (2000) Inorg Chem 39: 5603–5613
Cox JW, Berners-Price SJ, Davies MS, Qu Y, Farrell N (2001) J Am Chem Soc 123: 1316–1326
Berners-Price SJ, Davies MS, Cox JW, Thomas DS, Farrell N (2003) Chem Eur J 9: 713–725
Hegmans A, Berners-Price SJ, Davies MS, Thomas DS, Humphreys AS, Farrell N (2004) J Am Chem Soc 126: 2166–2180
Berners-Price SJ, Sadler PJ (1996) Coord Chem Rev 151: 1–40
Oehlsen M, Qu Y, Farrell N (2003) Inorg Chem 42: 5498–5506
Oehlsen ME, Hegmans A, Qu Y, Farrell N (2005) Inorg Chem 44:3004–3006
Oehlsen ME, Hegmans A, Qu Y, Farrell N (2005) J Biol Inorg Chem (published online: 10 August 2005)
Davies MS, Cox JW, Berners-Price SJ, Barklage W, Qu Y, Farrell N (2000) Inorg Chem 39: 1710–1715
Piotto M, Saudek V, Sklenar V (1992) J Biomol NMR 2: 661–665
Sklenar V, Piotto M, Leppik R, Saudek V (1993) J Magn Res Ser A 102: 241–245
Palmer AG III, Cavanagh J, Wright PE, Rance M (1991) J Magn Res 93: 151–170
Davies MS, Thomas DS, Hegmans A, Berners-Price SJ, Farrell N (2002) Inorg Chem 41: 1101–1109
Yao S, Plastaras JP, Marzilli LG (1994) Inorg Chem 33: 6061–6077
Hofmann A, Jaganyi D, Munro OQ, Liehr G, Van Eldik R (2003) Inorg Chem 42: 1688–1700
Jaganyi D, Hofmann A, Van Eldik R (2001) Angew Chem Int Ed 40: 1680–1683
Schmülling M, Grove DM, van Koten G, Van Eldik R, Veldman N, Spek AL (1996) Organometallics 15: 1384–1391
Gonnet F, Reeder F, Kozelka J, Chottard J-C (1996) Inorg Chem 35: 1653–1658
Appleton TG, Hall JR, Ralph SF, Thompson CSM (1989) Inorg Chem 28: 1989–1993
Lim MC, Martin RB (1976) Inorg Nucl Chem 38: 1911–1914
Guo Z, Chen Y, Zang E, Sadler PJ (1997) J Chem Soc, Dalton Trans: 4107–4111
Arpalahti J, Lehikoinen P (1990) Inorg Chem 29: 2564–2567
Erickson LE, Erickson HL, Meyer TH (1987) Inorg Chem 26: 997–999
Alcock RM, Hartley FR, Rogers DE (1973) J Chem Soc, Dalton Trans 1070–1073
Hofmann A, Van Eldik R (2003) J Chem Soc Dalton Trans 2979–2985
Bose RN, Goswami N, Moghaddas S (1990) Inorg Chem 29: 3461–3467
Jennerwein M, Andrews PA (1995) Drug Metab Dispos 23: 178–184
Roberts JD, Peroutka J, Farrell N (1999) J Inorg Biochem 77: 51–57
Berners-Price SJ, Frenkiel TA, Frey U, Ranford JD, Sadler PJ (1992) J Chem Soc Chem Commun 789–791
Acknowledgements
This work was supported by the Australian Research Council, US National Institutes of Health (R01-CA78754) and the American Cancer Society (RPG89-002-11-CDD). We thank Dr. Alexander Hegmans for the preparation of 15N-1,1/c,c and Drs. Tony Reeder and Lindsay Byrne for the assistance with the mass spectrometry and NMR experiments, respectively.
Author information
Authors and Affiliations
Corresponding authors
Electronic supplementary material
Rights and permissions
About this article
Cite this article
Zhang, J., Thomas, D.S., Davies, M.S. et al. Effects of geometric isomerism in dinuclear platinum antitumor complexes on aquation reactions in the presence of perchlorate, acetate and phosphate. J Biol Inorg Chem 10, 652–666 (2005). https://doi.org/10.1007/s00775-005-0013-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00775-005-0013-5